The global Epilepsy Drugs Market witnessed substantial growth in 2022, reaching a total value of USD 6.45 billion. Projections indicate that this market is poised for further expansion, with expectations of reaching a value of USD 9.22 billion by 2032. This forecasted growth is attributed to a robust compound annual growth rate (CAGR) of 3.7% over the forecast period. Several key factors are driving this impressive trajectory. https://www.reportsanddata.com/report-detail/epilepsy-drugs-market